Pathology Analysis & Statistics, July 2014 (p30)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: cancer, breast cancer, leukemia, more »

871-920 of about 4 100 reports

Purchase Reports From Reputable Market Research Publishers

EU5 Hernia Repair Procedures Outlook to 2020

EU5 Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • July 2014
  • by Global Data

EU5 Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "EU5 Hernia Repair Procedures Outlook to 2020", provides key market data on the Europe Hernia Repair Procedures. The report ...

  • Industries : Pathology
  • Countries : France, Germany, United Kingdom, Spain, Italy, Europe
Asia-Pacific Hernia Repair Procedures Outlook to 2020

Asia-Pacific Hernia Repair Procedures Outlook to 2020

  • $ 450
  • Industry report
  • July 2014
  • by Global Data

Asia-Pacific Hernia Repair Procedures Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Procedures Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repai ...

  • Industries : Pathology
  • Countries : South Korea, Australia, China, India, Japan, Asia, World, Oceania
Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Competitor Analysis: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

  • $ 462
  • Industry report
  • August 2014
  • by La Merie Publishing

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as of August 2014 provides a competitor analysis in the development ...

  • Industries : Pathology
Competitor Analysis: Cardiovascular Peptides

Competitor Analysis: Cardiovascular Peptides

  • $ 396
  • Industry report
  • October 2014
  • by La Merie Publishing

Competitor Analysis: Cardiovascular Peptides The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, ...

  • Industries : Pathology
Cancer Research Technology Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cancer Research Technology Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pathology
Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, ...

  • Industries : Pathology
  • Countries : China, World, United States, India, Asia
AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

AB Science (Symbol:AB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
AGA Medical Holdings, Inc. (Symbol:AGAM) SWOT Analysis, Strategy, Revenues and Profits

AGA Medical Holdings, Inc. (Symbol:AGAM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

ALung Technologies, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Ampio Pharmaceuticals, Inc. (Symbol:AMPE) SWOT Analysis, Strategy, Revenues and Profits

Ampio Pharmaceuticals, Inc. (Symbol:AMPE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Israel
Applied Visual Sciences, Inc. (Symbol:APVS) SWOT Analysis, Strategy, Revenues and Profits

Applied Visual Sciences, Inc. (Symbol:APVS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

ARCA biopharma, Inc. (Symbol:ABIO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Arrhythmia Research Technology, Inc. (Symbol:HRT) SWOT Analysis, Strategy, Revenues and Profits

Arrhythmia Research Technology, Inc. (Symbol:HRT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Arrowhead Research Corporation (Symbol:ARWR) SWOT Analysis, Strategy, Revenues and Profits

Arrowhead Research Corporation (Symbol:ARWR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Atritech, Inc. SWOT Analysis, Strategy, Revenues and Profits

Atritech, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Autism Speaks, Inc. SWOT Analysis, Strategy, Revenues and Profits

Autism Speaks, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Denmark
BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Switzerland
Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Biofrontera AG (Symbol:B8F) SWOT Analysis, Strategy, Revenues and Profits

Biofrontera AG (Symbol:B8F) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Germany
Biological Signal Processing Ltd. (Symbol:BSP) SWOT Analysis, Strategy, Revenues and Profits

Biological Signal Processing Ltd. (Symbol:BSP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Bionomics Limited (Symbol:BNO) SWOT Analysis, Strategy, Revenues and Profits

Bionomics Limited (Symbol:BNO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
BioSyent Inc. (Symbol:RX) SWOT Analysis, Strategy, Revenues and Profits

BioSyent Inc. (Symbol:RX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada
Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

Bone Medical Limited (Symbol:BNE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

Can-Fite BioPharma Ltd. (Symbol:CFBI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Israel
Cancer Research Technology Limited SWOT Analysis, Strategy, Revenues and Profits

Cancer Research Technology Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United Kingdom, United States
About 40 000 reports

Download Unlimited Documents from Trusted Public Sources

Janssen - Company Report, October 2014

  • Imbruvica® (ibrutinib) Supplemental New Drug Application Submit...
  • October 2014
    4 pages
  • Pathology  

  • United States  

View report >

About 100 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

C.R. Bard Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.